James M. Bennett - Concepedia

Author

James M. Bennett

Also Known As

Bennett, James, Bennett, James M., Bennett, John M., Dornsife, Ronna E., J. Bennett, J. M Bennett, J. M. Bennett, J.M. Bennett, JM Bennett, James M. Bennett

166

Publications

4.4K

Citations

H-Index

118

Concepts

All Affiliations

University of Oxford Genomics England Universidade Estadual de Campinas (UNICAMP)Genomics (United Kingdom)University of Johannesburg

About

James M. Bennett is an author at University of Oxford specializing in medicine, natural sciences, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	27	2.4K
2	Natural Sciences	17	19	1.4K
3	Health Sciences	5	5	582
4	Engineering	4	4	331
5	Public Health	1	1	92

James M. Bennett

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
An Inhibitor of FtsZ with Potent and Selective Anti-Staphylococcal Activity David J. Haydon, Neil R. Stokes, Rebecca Ure, Science Selective Anti-staphylococcal ActivityPharmacotherapyAntimicrobial ChemotherapyDrug ResistanceTaxol-binding Site	2008	436
Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening Efrat Resnick, A.R. Bradley, Jinrui Gan, Journal of the American Chemical Society Chemical BiologySelective ProbesBiochemistryNatural SciencesSelectivity Challenge	2019	323
Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking M. Schuller, G.J. Correy, Stefan Gahbauer, Science Advances EngineeringNsp3 MacrodomainMolecular BiologyViral Structural ProteinVirus Structure	2021	198
LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor Peter G. K. Clark, Lucas Campos Curcino Vieira, C. Tallant, Angewandte Chemie International Edition Lead ScaffoldMolecular PharmacologyMedicinal ChemistryDiversity Oriented SynthesisBiochemistry	2015	162
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors Melissa L. Boby, D. Fearon, Matteo P. Ferla, Science	2023	158
LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor Peter G. K. Clark, Lucas Campos Curcino Vieira, C. Tallant, Angewandte Chemie	2015	124
Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells Edward A. McKenzie, Kathryn Young, Margaret L. Hircock, Biochemical Journal	2003	115
Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF James M. Bennett, Oleg Fedorov, C. Tallant, Journal of Medicinal Chemistry Combinatorial ChemistryDrug TargetProtein Interaction ModuleMolecular BiologyChemical Biology	2015	111
Novel Inhibitors of Bacterial Cytokinesis Identified by a Cell-based Antibiotic Screening Assay Neil R. Stokes, Jörg Sievers, Stephanie Barker, Journal of Biological Chemistry	2005	109
Creating an Antibacterial with in Vivo Efficacy: Synthesis and Characterization of Potent Inhibitors of the Bacterial Cell Division Protein FtsZ with Improved Pharmaceutical Properties David J. Haydon, James M. Bennett, David R. Brown, Journal of Medicinal Chemistry	2010	103

Page 1